Publications by authors named "Isabelle Paty"

Claim this Profile
E
Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study.
Wesley Tyler Abplanalp, Ariane Fischer, David John, Andreas M Zeiher, Willy Gosgnach, Isabelle Paty

Nucleic Acid Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Somatostatin-Dopamine Chimera (BIM23B065) Reduced GH Secretion in a First-in-Human Clinical Trial.
Wadim M I de Boon, Michiel J van Esdonk, Frederik E Stuurman, Nienke R Biermasz, Laurent Pons, Isabelle Paty

J Clin Endocrinol Metab· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequipotency of idraparinux and idrabiotaparinux after once weekly dosing in healthy volunteers and patients treated for acute deep vein thrombosis.
Marc Trellu, Jean-Baptiste Fau, Pierre Cortez, Sue Cheng, Isabelle Paty

Br J Clin Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Joris C Verster, Edmund R Volkerts, Antonia H C M L Schreuder, Erik J E Eijken, Janet H G van Heuckelum, Isabelle Paty

J Clin Psychopharmacol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.
Annemiek Vermeeren, Wim J Riedel, Martin P J van Boxtel, Mona Darwish, Isabelle Paty

Sleep· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
Barbara M Stone, Claire Turner, Sue L Mills, Isabelle Paty, Alain Patat

Br J Clin Pharmacol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.
Alain Patat, Isabelle Paty, Ian Hindmarch

Hum Psychopharmacol· July 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening.
Ian Hindmarch, Alain Patat, Neil Stanley, Isabelle Paty, Una Rigney

Hum Psychopharmacol· March 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis